Miriam Greene

Featured in:

Articles

A Novel Multi-strain Vaginal Synbiotic is Effective in Optimizing the Vaginal Microbiome: Results from a Randomized, Placebo-controlled Clinical Trial

May 21, 2024 | medrxiv.org | Jacques Ravel |Eleni Jaswa |Sara Gottfried |Miriam Greene

DG is an employee/shareholder at Seed Health. JR is co-founder of LUCA Biologics, a biotechnology company focusing on translating microbiome research into live biotherapeutics drugs for women's health. DH serves as an advisor/consultant at Seed Health. NCT05659745This study was funded by Seed Health. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.